Diversified Trust’s AstraZeneca AZN Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q3  | $458K | Sell | 
         | 
    |||||
| 
        
          
      
        2025
         Q2  | $498K | Buy | 
         | 
    |||||
| 
        
          
      
        2025
         Q1  | $446K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $369K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $415K | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $416K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $294K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $276K | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $441K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $319K | Buy | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $299K | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $315K | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $256K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $263K | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $302K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $232K | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $244K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $647K | Buy | 
         |